Breviscapine protects against pathological cardiac hypertrophy by targeting FOXO3a-mitofusin-1 mediated mitochondrial fusion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breviscapine protects against pathological cardiac hypertrophy by targeting FOXO3a-mitofusin-1 mediated mitochondrial fusion

Published:2024-02 Issue: Volume:212 Page:477-492
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Lin Xiaobing,Fei Ming-Zhou,Huang An-Xian,Yang Liu,Zeng Ze-Jie,Gao Wen^ORCID

Publisher

Elsevier BV

Reference60 articles.

1. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur. Heart J.,2021

2. Physiological and pathological cardiac hypertrophy;Shimizu;J. Mol. Cell. Cardiol.,2016

3. Reverse remodelling and myocardial recovery in heart failure;Kim;Nat. Rev. Cardiol.,2018

4. Mitochondrial integrity is critical in right heart failure development;Müller;Int. J. Mol. Sci.,2023

5. Mitochondrial dysfunction in heart failure with preserved ejection fraction;Kumar;Circulation,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and Mitochondrial Pathways Contribute to SGLT2 Inhibitors-mediated Tissue Protection: Experimental and Clinical Data;Current Pharmaceutical Design;2024-04

2. Survey of Commonly-Used Traditional Chinese Medicine Injections for Cardiovascular Disease;Advances in Clinical Medicine;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP